Home › Funds › PRIMECAP Odyssey Growth Fund
Fund family: PRIMECAP Odyssey Funds · Filed by PRIMECAP Odyssey Funds (CIK 1293967) · SEC series S000005540
Ticker: POGRX (C000015070)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,118 with, 133 against, 4 abstentions (not counted as with management); 38 items carried no recommendation. Shareholder proposals: 9 FOR, 125 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other PRIMECAP Odyssey Funds funds is possible: fewer than three other funds of the family voted in 2025-2026.
The same votes as “with management” above, by the sector of the company voted on. 85.6% of this fund’s 2,255 such votes could be given a sector; the other 324 (14.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 535 | 34 | 6.4% |
| Technology | 533 | 53 | 9.9% |
| Health Care | 271 | 12 | 4.4% |
| Industrials | 264 | 13 | 4.9% |
| Finance | 176 | 13 | 7.4% |
| Energy | 102 | 6 | 5.9% |
| Consumer Staples | 24 | 1 | 4.2% |
| Basic Materials | 15 | 1 | 6.7% |
| Real Estate | 11 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,523 | 2 |
| Audit-related | 185 | 0 |
| Say-on-Pay | 176 | 1 |
| Corporate Governance | 161 | 51 |
| Capital Structure | 83 | 1 |
| Compensation | 63 | 3 |
| Other Social Issues | 26 | 23 |
| Other | 25 | 4 |
| Human Rights or Human Capital/workforce | 20 | 20 |
| Environment or Climate | 16 | 16 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| MICRON TECHNOLOGY, INC. | January 15, 2026 | $838M | 12 | 1 |
| XOMETRY, INC. | June 16, 2026 | $437M | 5 | 0 |
| ELI LILLY AND COMPANY | May 4, 2026 | $351M | 10 | 2 |
| INTEL CORPORATION | May 13, 2026 | $166M | 18 | 3 |
| BIOGEN INC. | June 9, 2026 | $155M | 12 | 0 |
| ALPHABET INC. | June 5, 2026 | $134M | 23 | 10 |
| MICROSOFT CORPORATION | December 5, 2025 | $127M | 21 | 6 |
| RHYTHM PHARMACEUTICALS, INC. | June 24, 2026 | $118M | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| January 15, 2026 | MICRON TECHNOLOGY, INC. | SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposal | Against | For |
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 13, 2026 | INTEL CORPORATION | Stockholder proposal requesting a report on risk of China exposure. Shareholder proposal | Against | For |
| May 13, 2026 | INTEL CORPORATION | Stockholder proposal requesting a report on Intel's human rights due diligence process. Shareholder proposal | Against | For |
| June 5, 2026 | ALPHABET INC. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | ALPHABET INC. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| December 5, 2025 | MICROSOFT CORPORATION | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | MICROSOFT CORPORATION | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA CORPORATION | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA CORPORATION | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 19, 2026 | AMGEN INC. | Stockholder proposal to require an independent board chairman. Shareholder proposal | Against | For |
2,302 ballot items at 181 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, PRIMECAP Odyssey Growth Fund (POGRX) voted at 181 shareholder meetings of 176 companies, on 2,302 ballot items in all. Where management made a recommendation, the fund followed it on 93.9% of the items and voted against it 133 times. Its most frequent area of disagreement was corporate governance (51 of its votes against management). It voted FOR 6.7% of the 134 shareholder proposals on which it cast a FOR or AGAINST vote.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.